Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06367959

Health Benefits of Writing Therapy Among Asian American Cancer Survivors

To learn more about participant experience as a Asian American immigrant breast cancer survivor and how writing about participant experiences may affect participant's health.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

About this study

Primary Objective:

To determine the effects of writing therapy on QOL and perceived stress at the 6- and 12-month follow-ups.

Secondary Objective:

To discover the effects of writing therapy on stress biomarkers and perceived stress at the 3-month follow-up.

To explore the psychosocial and cultural mechanisms responsible for the benefits of writing therapy by using mixed methods.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult (aged 18 and older) diagnosed with stage 0-III cancer (or acute leukemia in remission/ chronic myeloid leukemia in chronic phase).
  • Self-identified as Asian, Asian Americans, any Asian or Asian American subgroup (Chinese, Vietnamese, Indian, Korean, etc.) ethnic/cultural background
  • Completed primary treatment, including surgery, chemotherapy, and/or radiation therapy, immunotherapy, or targeted therapy within the preceding 5 years.
  • Comfortable reading in English or in Chinese.

Exclusion criteria

  • Inability to provide informed consent.

Treatment and study plan

Esays

Behavioral

Participants will write about their experiences One (1) time each week for 3 weeks at the beginning of the study and then 1 more time 9 months later. Participants will be asked to write about their experiences with cancer in English or Chinese and to write as much as they can for about 20-30 minutes for each essay.

Questionnaires

Behavioral

Participants will answer a questionnaire at the beginning of the study and then 3, 6, and 12 months later.

Participants will also answer a questionnaire about their thoughts on writing and on the study after they complete the third essay.

Primary outcomes

  1. Primary Outcome Measure: Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

    Time frame: Time Frame: through study completion; an average of 1 year

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Apr 16, 2024
Registry last updated
Jun 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.